Articles From: Five Prime Therapeutics Enters Into Antibody Research Collaboration Agreement With Adimab to Five9 Announces Pricing of Initial Public Offering


2014/1/9
SOUTH SAN FRANCISCO, Calif., Jan.
Sign-up for Five Prime Therapeutics Enters Into Antibody Research Collaboration Agreement With Adimab investment picks
2014/2/6
SOUTH SAN FRANCISCO, Calif., Feb.
Sign-up for Five Prime Therapeutics Prices Public Offering of Common Stock investment picks
2014/3/18
SOUTH SAN FRANCISCO, Calif., March 18, 2014 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) (Five Prime), a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, will report its fourth quarter and full year 2013 financial results on Tuesday, March 25, 2014, after the U.S. financial markets close.
Sign-up for Five Prime Therapeutics to Announce Fourth Quarter and Full Year 2013 Financial Results and Host Conference Call on March 25 investment picks
2013/10/29
SOUTH SAN FRANCISCO, Calif., Oct.
Sign-up for Five Prime Therapeutics to Announce Third Quarter 2013 Financial Results and Host Conference Call on November 12 investment picks
2014/3/5
SOUTH SAN FRANCISCO, Calif., March 5, 2014 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) , a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced that Aron Knickerbocker, Chief Business Officer of Five Prime, will present at the 26 th Annual Roth Conference on Tuesday, March 11 at 5:30 p.m. Pacific Time.
Sign-up for Five Prime Therapeutics to Present at 26th Annual Roth Conference investment picks
2014/2/3
SOUTH SAN FRANCISCO, Calif., Feb.
Sign-up for Five Prime Therapeutics to Present at BIO CEO investment picks
2014/3/20
SOUTH SAN FRANCISCO, Calif., March 20, 2014 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) , a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced that Lewis T.
Sign-up for Five Prime Therapeutics to Present at Future Leaders in the Biotech Industry investment picks
SOUTH SAN FRANCISCO, Calif., Nov.
Sign-up for Five Prime Therapeutics to Present at Piper Jaffray Healthcare Conference investment picks
2014/4/1
SOUTH SAN FRANCISCO, Calif., April 1, 2014 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) , a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced that Aron Knickerbocker, Chief Business Officer, will present at the 13 th Annual Needham Healthcare Conference on April 8, 2014 at 4:20 PM Eastern Time.
Sign-up for Five Prime Therapeutics to Present at the 13th Annual Needham Healthcare Conference investment picks
2013/9/11
http://media.marketwire.com/attachments/201309/TN-185790_LakeTahoeSpa.jpg No Lake Tahoe spa vacation is complete without a visit to The Ritz-Carlton Spa, Lake Tahoe.
Sign-up for Five Reasons Autumn Is Lake Tahoe's 'Secret Season' investment picks
2014/3/7
It’s the phone call from a stranger who claims your relative is in trouble and needs cash or an email that says you’ve won a prize for a contest you never entered.
Sign-up for Five Signs It’s a Scam! MoneyGram Spotlights Fraud Education investment picks
2014/3/17
Celebrity Chef Teams Up with Five Star in the Latest Series of Culinary Innovations NEWTON, Mass.
Sign-up for Five Star Quality Care Redefines the Senior Living Dining Experience investment picks
2014/4/8
Five Star Quality Care, Inc. (NYSE: FVE) announced that it has not timely filed its Annual Report on Form 10-K for the year ended December 31, 2013 (the “2013 Form 10-K”) in accordance with the requirements of the Securities Exchange Commission (“SEC”) and the New York Stock Exchange (“NYSE”). The reasons for the current delay are the same as those described in Five Star’s Form 12b-25 filing with the SEC made on March 18, 2014, except that more time is required to complete Five Star’s restated Annual Report on Form 10-K for the year ended December 31, 2012, the restated Quarterly Reports on Form 10-Q for each of the quarters ended March 31, 2013 and June 30, 2013, the Quarterly Report on Form 10-Q for the quarter ended September 30, 2013 and the 2013 Form 10-K (together, the “Reports”). Five Star expects that it will regain compliance with the NYSE listing standards
Sign-up for Five Star Quality Care, Inc. Announces Delayed Annual Report Filing investment picks
2014/2/28
Five Star Quality Care, Inc. (NYSE: FVE) today announced that the record date for determination of stockholders entitled to vote at the 2014 Annual Meeting of Stockholders is Monday, March 10, 2014.
Sign-up for Five Star Quality Care, Inc. Announces Record Date for 2014 Annual Meeting of Stockholders investment picks
Five Star Quality Care, Inc. (NYSE: FVE) (“FVE” or “Five Star”) today announced that effective December 31, 2013, it has transferred the operations of two rehabilitation hospitals to entities affiliated with Reliant Hospital Partners, LLC (Reliant) of Richardson, TX.
Sign-up for Five Star Quality Care, Inc. Completes Disposition of Rehabilitation Hospitals investment picks
2013/11/12
Five Star Quality Care, Inc. (NYSE:FVE) today announced certain preliminary financial data and information for the quarter and nine months ended September 30, 2013.
Sign-up for Five Star Quality Care, Inc. Reports Certain Third Quarter 2013 Financial Data investment picks
Five Star Quality Care, Inc. (NYSE: FVE) today announced that it will host a conference call in conjunction with the announcement of its third quarter 2013 financial results.
Sign-up for Five Star Quality Care, Inc. Third Quarter Conference Call Scheduled for Monday, October 28th investment picks
2014/1/14
Five Star Quality Care, Inc .
Sign-up for Five Star Quality Care, Inc. to Present at the Noble Financial Capital Markets Equity Conference on January 21, 2014 investment picks
Five Star Quality Care, Inc .
Sign-up for Five Star Quality Care, Inc. to Present at the Stifel 2013 Healthcare Conference on September 12, 2013 investment picks
Five Star Quality Care, Inc. (NYSE: FVE) today announced that it will restate its financial results for 2011, 2012 and the first and second quarters of 2013.
Sign-up for Five Star Quality Care, Inc. to Restate 2011, 2012 and First and Second Quarter 2013 Financial Results investment picks
2014/3/24
Five Strangers.
Sign-up for Five Strangers. Five Homes. W Network's Who Lives Here? Puts People in their Places investment picks
ZURICH-- Five state-backed Swiss banks said Monday they would participate in a U.S. disclosure program aimed at lenders suspected of having aided tax evasion by Americans, adding to the list of Swiss financial institutions agreeing to share information with U.S. authorities.
Sign-up for Five Swiss Banks Agree to Join U.S. Tax Plan investment picks
2013/12/16
By John Revill ZURICH--
Sign-up for Five Swiss Banks Agree To Participate in U.S. Tax Plan investment picks
2014/1/13
http://media.marketwire.com/attachments/201401/TN-214974_1500iD_blue-HI-RES.jpg The 1500iD Speed Dial set-your-own combination padlock opens on directional up-down-left-right movements for faster, easier operation.
Sign-up for Five Tips for Sticking to Your Fitness Resolutions investment picks
Jones Lang LaSalle's Op-Ex Advantage report makes the investment case for automated building systems CHICAGO , Nov.
Sign-up for Five Trends Making Smart Building Technology a No-Brainer for Real Estate Investors investment picks
Findings from five years of the CREATE survey series (2009-2013), developed by CREATE-Research and commissioned by Principal Global Investors , reveal a surge in popularity for income-focused funds among investors seeking a new form of diversification .
Sign-up for Five Years After Financial Crisis, Investors Chasing Regular Income Over High Returns investment picks
2013/10/23
HOLLISTON, Mass., Oct.
Sign-up for Five-Year Follow-Up of World's First Regenerated Trachea Transplant Published in The Lancet investment picks
2014/4/4
ADVISORY, April 4, 2014 (GLOBE NEWSWIRE) -- What: Five9 [FIVN], a pioneer and leading provider of cloud software for contact centers, will visit the NASDAQ MarketSite in Times Square in celebration of its initial public offering (IPO) which occurred on The NASDAQ Stock Market today, April 4.
Sign-up for Five9 [FIVN] to Ring The NASDAQ Stock Market Opening Bell in Celebration of IPO investment picks
2014/4/3
SAN RAMON, Calif., April 3, 2014 (GLOBE NEWSWIRE) -- Five9, Inc. (Nasdaq:FIVN) announced today the pricing of its initial public offering of 10,000,000 shares of its common stock at a price to the public of $7.00 per share.
Sign-up for Five9 Announces Pricing of Initial Public Offering investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Five Prime Therapeutics Enters Into Antibody Research Collaboration Agreement With Adimab to Five9 Announces Pricing of Initial Public Offering
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity